I agree ohm. However, unless they plan to keep can
Post# of 148187
(Total Views: 408)
Posted On: 11/20/2019 9:43:57 PM
I agree ohm. However, unless they plan to keep cancer or NASH, this is the best option IMO (although it puts a clock on shareholder value). They don’t (currently) have the expertise to build a research team, acquire early stage drug candidates, commercialize products etc.
If they keep cancer or NASH that would tell me they intend to build these teams, but at this point I think they are focused on the 5 meter targets and not shooting at the 300 meter targets until they get a few closer targets knocked down.
If they keep cancer or NASH that would tell me they intend to build these teams, but at this point I think they are focused on the 5 meter targets and not shooting at the 300 meter targets until they get a few closer targets knocked down.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
Scroll down for more posts ▼